Logo

People in the News: Lee Hood to Serve as Scientific Advisor to Sera Prognostics

Sep 06, 2013
Premium

Sera Prognostics said this week that Lee Hood will serve as a scientific advisor to the company.

Hood is a co-founder and president of the Institute for Systems Biology. He is a life sciences entrepreneur who has been involved in the founding of firms such as Applied Biosystems, Integrated Diagnostics, Amgen, and others. Hood is also a member of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine.

Sera said that Hood will help the company develop clinical proteomic technologies to deliver advanced diagnostic information to women and their physicians to improve pregnancy outcomes.

Filed under

Proteomics & Protein Research
ISB
proteomics
Sera Prognostics
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.